Aired 1 year ago 30:08

Cracking the Code on Brand Growth

The battle for business growth does not start online or on store shelves. Rather, it takes place in the subconscious mind of prospective customers, write Michael Platt and Leslie Zane in this opinion piece.

Aired 6 months ago 30:04

Karima Moyer-Nocchi: Italian Foodways and the Myth of Authenticity

Pasta. Olive oil. Polenta. Much of Italian cuisine today has come to be defined by staples like these and their associated dishes (with strict recipes and rules to boot!). Yet how did we arrive at these ideas? Karima Moyer-Nocchi is a food historian who looks at the development of the Italian culinary landscape. She discusses … Continue reading Karima Moyer-Nocchi: Italian Foodways and the Myth of Authenticity →

Aired 7 months ago 29:04

Political narcissism and the soft diplomacy of beekeeping

Tim Soutphommasane on the 'political narcissism of minor differences'. The soft diplomacy of beekeeping.

Aired 1 year ago 38:35

Episode 22: Practice, Pitfalls, and Possibilities

Welcome back to Season 4! In this latest episode, we take a look at data from immunotherapy clinical trials from several different angles and investigate the challenges associated presented by different combination partners, control arms, patient populations, biomarkers, line of therapy, etc. When important phase 3 readouts hit the newswires, inevitable questions follow: - Is the data practice changing? - Which regimen should be used with which patient population? - What happens on the Weds after the conference in the clinic when a new patient presents; will oncologists do anything differently? While it's nice to have several positive trial results, how do physicians go about making sense of them? What are some of the hidden pitfalls of cross-trial comparisons that we should watch out for and consider? Professor Tom Powles (Barts Cancer Centre, London) is our narrator for this show and walks us through various challenges and opportunities that both investigators and oncologists face. We explore various examples from recent randomised clinical trial results in lung, renal and bladder cancers, as well as metastatic melanoma.   Along the way, we interview numerous experts who have treated cancer patients with several different types of therapy and participated in clinical trials, including Drs Roy Herbst (Yale), Hossein Borghaei (Fox Chase), Jack West (Swedish), Alan Sandler (Genentech) in lung cancer. Other specialists discuss the underlying science and practical aspects they have experienced to help illustrate the challenges and opportunities that the complexity in unravelling cancer presents and look at how emerging biomarkers can help. These include Professor Charles Swanton FRS and Dr Nicky McGranahan (UCL), Drs David Fabrizio (Foundation Medicine) and Kunle Odunsi (Roswell Park).   We also touch on the future and how important 'big data' is becoming, not just in terms of clinical trials, but the possibilities that it offers for personalising therapy. Dr Lizzie Coker (now at Sanger Institute) explains how her work on developing a public repository is intended to empower basic scientists with big datasets and the value of social media for young researchers. You can find more information in the show notes on https://noveltargets.com © 2018 Blue Ice Publishing LLC. All Rights Reserved.

Aired 1 year ago 11:56

Federation ends! President talks on Spock's & Friends

President Brunt's plan to build a wall around the Neutral Zone. Plus, environmental damage from another pneumatic pipeline spill, and Marshall College adds Creationism to its curriculum. Featuring: Chris Cooley as Bob, Morgan Cranny as Cyril, Christina Patterson as Carol, and David Radford as the Dean - in - "Regarding Henry Jones" Produced by Launch Pad Theatre Company Written, Directed, and Performed by David Radford Ambassador of Techmedia Direction Christina Patterson www.launchpadtheatre.com